Dr Buttery qualified from Cambridge and Oxford University in 1992 and undertook junior doctor training in Oxford, then in Cambridge, before moving to Edinburgh to complete his specialist training in respiratory medicine. Whilst there he developed an interest in lung cancer and studied the regulation of integrin affinity in the molecular biology of lung cancer.
This resulted in a number of original research articles in peer-reviewed journals and the award of PhD in 2006. In 2005 he studied the application of endobronchial ultrasound in Heidelberg under Prof. Felix Herth, supported by the European Respiratory Society, before taking up post in Papworth. At Papworth, his role is focussed on the diagnosis and management of lung cancer and malignant mesothelioma, including endobrochial treatment and pleural disease management. He has a special interest in smoking cessation, which he hopes to broaden to the wider community, and he was until recently a member of the BTS specialist advisory group on smoking cessation. Additionally, he acts as a busy respiratory and general physician at Hinchingbrooke Hospital in Huntingdon.
Thoracic Oncology (lung cancer and mesothelioma), smoking cessation, COPD.
Lung cancer, smoking cessation.
BA (Nat. Sci. Medical Sciences Tripos) University of Cambridge Class I 1989
BM, BCh, University of Oxford 1992
Member of Royal College of Physicians 1995
Specialist Registrar in Respiratory and General (Internal) Medicine 1996-2004 Edinburgh
Certification of Completion of Specialist Training 2004
European Respiratory Society Fellowship for training in Heidelberg (2005)
PhD in molecular biology of lung cancer, University of Edinburgh, 2006
Fellow of the Royal College of Physicians of London
Fellow of the Royal College of Physicians of Edinburgh
Member of the British Thoracic Society
Recent member of British Thoracic Society Specialist Advisory Group for smoking cessation
Tournoy KG, Rintoul RC, van Meerbeeck JP, Carroll NR, Praet M, Buttery RC, van Kralingen KW, Rabe KF, Annema JT (2008). EBUS-TBNA for the diagnosis of central parenchymal lung lesions not visible at routine bronchoscopy. Lung Cancer. 2009 Jan; 63 (1): 45-9. Epub 2008 Jun 2.
Rintoul RC, Tournoy KG, El Daly H, Carroll NR, Buttery RC, van Kralingen K, van Meerbeeck JP, Rabe KF, Annema JT (2009). EBUS-TBNA for the clarification of PET positive intra-thoracic lymph nodes-an international multi-centre experience. J Thorac Oncol. 2009 Jan; 4 (1): 44-8.
Buttery RC, Monaghan H, Salter DMS, Sethi T (2004). Galectin-3: Differential expression between small cell and non-small cell lung cancer. Histopathology; 44 (4): 339 – 44.
Buttery RC, Rintoul RC, Sethi T (2004). Small cell lung cancer: the importance of the extracellular matrix. International Journal of Biochemistry and Cell Biology Jul; 36 (7): 1154 – 60.
Buttery RC , van Meerbeeck JP, Rabe KF, Annema JT (2009). EBUS-TBNA for the clarification of PET positive intra-thoracic lymph nodes-an international multi-centre experience. J Thorac Oncol. 2009 Jan; 4 (1): 44-8.
Buttery RC, Rintoul RC, MacKinnon, AC, Wong WS, Mosher D, Haslett C and Sethi T (2002). Cross-linking CD98 promotes integrin-like signaling and anchorage-independent growth. Molecular Biology of the Cell; 13 (8): 2841
